Once-daily oral senicapoc treatment of the 2 more slowly progressive Pkd1 mouse models for 12 wk markedly attenuated renal cyst growth and number, reduced fibrosis, and slowed deterioration of renal function. The gene discussed is PKD1; the disease is cystic kidney disease.